BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23154542)

  • 1. EGFR gene mutations: is it prognostic or predictive in surgically resected lung cancer?
    Mitsudomi T; Tada H
    J Thorac Oncol; 2012 Dec; 7(12):1739-1741. PubMed ID: 23154542
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan.
    Liu HP; Isaac Wu HD; Chang JW; Wu YC; Yang HY; Chen YT; Hsieh WY; Chen YT; Chen YR; Huang SF
    J Thorac Oncol; 2010 Aug; 5(8):1175-84. PubMed ID: 20559151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
    Lee JS; Kim HR; Lee CY; Shin M; Shim HS
    Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.
    Sriram KB; Tan ME; Savarimuthu SM; Wright CM; Relan V; Stockwell RE; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
    Eur Respir J; 2011 Oct; 38(4):903-10. PubMed ID: 21349912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR mutation testing for squamous cell lung carcinoma.
    Liam CK; Leow HR; Pang YK
    J Thorac Oncol; 2013 Dec; 8(12):e114. PubMed ID: 24389448
    [No Abstract]   [Full Text] [Related]  

  • 8. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.
    Na II; Rho JK; Choi YJ; Kim CH; Koh JS; Ryoo BY; Yang SH; Lee JC
    J Korean Med Sci; 2007 Jun; 22(3):393-9. PubMed ID: 17596643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.
    Weber B; Hager H; Sorensen BS; McCulloch T; Mellemgaard A; Khalil AA; Nexo E; Meldgaard P
    Lung Cancer; 2014 Feb; 83(2):224-30. PubMed ID: 24388704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact?
    Ye X; Zhu ZZ; Zhong L; Lu Y; Sun Y; Yin X; Yang Z; Zhu G; Ji Q
    J Thorac Oncol; 2013 Sep; 8(9):1118-20. PubMed ID: 23945382
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations.
    Kim TJ; Lee CT; Jheon SH; Park JS; Chung JH
    Ann Thorac Surg; 2016 Feb; 101(2):473-80. PubMed ID: 26454747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
    Hung KS; Lee CN; Liu HE
    J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Takenaka T; Takenoyama M; Yamaguchi M; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Yoshida T; Shiraishi Y; Morodomi Y; Hirai F; Taguchi K; Shimokawa M; Seto T; Ichinose Y
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):550-5. PubMed ID: 24894095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Is the Issue for Diagnosis of EGFR T790M Mutation.
    Khan J; Pritchard CC; Martins RG
    J Thorac Oncol; 2016 Jul; 11(7):e91-2. PubMed ID: 27339415
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
    Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
    J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.
    Kondo M; Yokoyama T; Fukui T; Yoshioka H; Yokoi K; Nagasaka T; Imaizumi K; Kume H; Hasegawa Y; Shimokata K; Sekido Y
    Lung Cancer; 2005 Dec; 50(3):385-91. PubMed ID: 16140420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.
    da Cunha Santos G; Saieg MA; Geddie W; Leighl N
    Cancer Cytopathol; 2011 Apr; 119(2):80-91. PubMed ID: 21400669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.